Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

Intrapatient Variability of Efavirenz Concentrations as a Predictor of Virologic Response to Antiretroviral Therapy

Richard Brundage, Florence H. Yong, Terrence Fenton, Stephen A. Spector, Stuart E. Starr, Courtney V. Fletcher. Intrapatient Variability of Efavirenz Concentrations as a Predictor of Virologic Response to Antiretroviral Therapy. Antimicrobial Agents and Chemotherapy. 2004. 48: 979-984.

Year

2004

Journal

Antimicrobial Agents and Chemotherapy

Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings

Anish P. Mahajan, Joseph W. Hogan, Brad Snyder, Nagalingeshwaran Kumarasamy, Kalindi Mehta, Suniti (Daralak) Solomon, Charles Carpenter, Kenneth H. Mayer, Timothy P. Flanigan. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. 2004. 36: 567-75.

Year

2004

Journal

Journal of Acquired Immune Deficiency Syndromes

Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy

Richard A. Zuckerman, William L.H. Whittington, Connie Celum, Tarquin Collis, Aldo J. Lucchetti, Jorge L. Sanchez, James P. Hughes, Jose L. Sanchez, Robert W. Coombs. Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. Journal of Infectious Diseases. 2004. 190: 156-61.

Year

2004

Journal

Journal of Infectious Diseases

Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains

Susan H. Eshleman, John Hackett, Priscilla Swanson, Shawn P. Cunningham, Sushil G. Devare, Catherine Brennan, Birgit Drews, Leopold Zekeng, Lazare Kaptue. Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. Journal of Clinical Microbiology. 2004. 42: 2711-7.

Year

2004

Journal

Journal of Clinical Microbiology

Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine

Ulrich A. Walker, J. Bauerle, M. Laguno, J. Murillas, Stefan Mauss, G. Schmutz, B. Setzer, R. Miquel, Jose M. Gatell Artigas, J. Mallolas. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology. 2004. 39: 311-7.

Year

2004

Journal

Hepatology

Pharmacokinetics and Tolerance of Zidovudine in Preterm Infants

Edmund Capparelli, Mark Mirochnick, Wayne M. Dankner, Wayne Mathew Dankner, Suzette Blanchard, Suzette Blanchard, Lynne M. Mofenson, Lynne M. Mofenson, George D. McSherry, George D. McSherry, Hannah Gay, Gregory Ciupak, Gregory Ciupak, Hannah Gay, Gregory Ciupak, Elizabeth (Betsy) Smith, Elizabeth Smith, James D. Connor, Barbara A. Smith, James D. Connor, Mark Mirochnick. Pharmacokinetics and Tolerance of Zidovudine in Preterm Infants. Journal of Pediatrics. 2003. 142: 47-52.

Year

2003

Journal

Journal of Pediatrics

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

Christina M. Marra, D. Lockhart, J. R. Zunt, Margot Perrin, Robert W. Coombs, Ann C. Collier. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology. 2003. 60: 1388-90.

Year

2003

Journal

Neurology

Lymphocyte subsets in healthy children from birth through 18 years of age: the PACTG 1009 Study.

William T. Shearer, Howard Max Rosenblatt, Rebecca S. Gelman, Rebecca Oyomopito, Susan Plaeger, E. Richard Stiehm, Diane W. Wara, Steven D. Douglas, Katherine Luzuriaga, Elizabeth (Betsy) J. McFarland, Ram Yogev, Mobeen H. Rathore, Wende Levy, Bobbie L. Graham, Stephen A. Spector. Lymphocyte subsets in healthy children from birth through 18 years of age: the PACTG 1009 Study.. Journal of Allergy and Clinical Immunology. 2003. 112: 973-80.

Year

2003

Journal

Journal of Allergy and Clinical Immunology

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.

C. Soh, James M. Oleske, Michael T. Brady, Stephen A. Spector, William Borkowsky, Sandra K. Burchett, M. Foca, Edward Handelsman, Eleanor Jimenez, Wayne Mathew Dankner, Michael Hughes. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.. Lancet. 2003. 362: 2045-2051.

Year

2003

Journal

Lancet

Short-term risk of disease progression in HIV-1 infected children receiving no antiretroviral therapy or zidovudine monotherapy: estimates according to CD4 percent viral load, and age.

David Dunn, Ross E. McKinney, Lynne M. Mofenson, John ( Jack ) Moye, Paul Palumbo, William T. Shearer. Short-term risk of disease progression in HIV-1 infected children receiving no antiretroviral therapy or zidovudine monotherapy: estimates according to CD4 percent viral load, and age.. Lancet. 2003. 362: 1605-11.

Year

2003

Journal

Lancet